Capstone Investment Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-108,665
| Closed | -$773K | – | 984 |
|
|
2025
Q1 | $773K | Hold |
108,665
| – | – | ﹤0.01% | 364 |
|
|
2024
Q4 | $1.27M | Buy |
108,665
+47,536
| +78% | +$554K | ﹤0.01% | 336 |
|
|
2024
Q3 | $1.26M | Buy |
61,129
+831
| +1% | +$17.1K | ﹤0.01% | 254 |
|
|
2024
Q2 | $1.35M | Buy |
+60,298
| New | +$1.35M | ﹤0.01% | 275 |
|
|
2024
Q1 | – | Sell |
-59,380
| Closed | -$1.81M | – | 1457 |
|
|
2023
Q4 | $1.81M | Buy |
59,380
+10,048
| +20% | +$306K | 0.01% | 236 |
|
|
2023
Q3 | $1.56M | Buy |
49,332
+38,164
| +342% | +$1.21M | 0.01% | 308 |
|
|
2023
Q2 | $455K | Buy |
+11,168
| New | +$455K | ﹤0.01% | 464 |
|